Amy E McKee insider trades
Open-market stock purchases and sales by Amy E McKee, Director at Biocryst Pharmaceuticals Inc, from SEC Form 4 filings since Sep 20, 2021.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Aug 31, 2026 | BCRX Biocryst Pharmaceuticals Inc | Bought (not open market) | $6.2K |
| Jun 11, 2026 | BCRX Biocryst Pharmaceuticals Inc | Bought (not open market) | — |
| Jun 11, 2026 | BCRX Biocryst Pharmaceuticals Inc | Bought (not open market) | — |
| May 29, 2026 | BCRX Biocryst Pharmaceuticals Inc | Bought (not open market) | $5.6K |
| May 18, 2026 | BCRX Biocryst Pharmaceuticals Inc | Sold | $100K |
| Feb 27, 2026 | BCRX Biocryst Pharmaceuticals Inc | Bought (not open market) | $5.6K |
| Nov 28, 2025 | BCRX Biocryst Pharmaceuticals Inc | Bought (not open market) | $5.6K |
Companies traded
- BCRX Biocryst Pharmaceuticals Inc: 2 sales, last Aug 31, 2026